Schedule Appointment

Eduardo Hariton, M.D., MBA

Board Certified Board Certified

  • Obstetrics and Gynecology
  • Reproductive Endocrinology and Infertility
  • Language Spoken: Spanish

Meet Dr. Eduardo Hariton

Eduardo Hariton, M.D., MBA, is a renowned reproductive endocrinologist whose expertise, innovation, and compassionate care have helped countless individuals and couples grow their families.  He is widely respected in the Bay Area fertility community and is known for his patient-centered approach that consistently earns high patient satisfaction.

After earning his medical degree from Harvard Medical School, he completed a residency in Obstetrics and Gynecology at Brigham and Women’s Hospital and Massachusetts General Hospital in Boston. Dr. Hariton further honed his expertise with a fellowship in Reproductive Endocrinology and Infertility at the University of California, San Francisco. Complementing his medical training, he also holds a master’s in business administration from Harvard Business School, enhancing his ability to lead and innovate in fertility medicine.

Dr. Hariton has received numerous accolades, including recognition for his groundbreaking thesis research, which applied artificial intelligence to improve IVF outcomes. With over 70 high-impact research publications, abstracts, and presentations, he remains at the forefront of reproductive medicine, combining the latest advancements with compassionate, patient-centered care. Outside of his clinical practice, Dr. Hariton leads the US Fertility Innovation Fund and leads strategic initiatives across the network.

Dr. Hariton’s clinical expertise includes polycystic ovary syndrome (PCOS), recurrent pregnancy loss, egg freezing, diminished ovarian reserve, uterine fibroids, and the integration of cutting-edge technologies like artificial intelligence to enhance IVF success rates. He provides patient care at RSC’s Oakland and San Ramon locations, where his commitment to individualized care has made him a trusted choice for patients throughout the Bay Area.

Outside of the clinic, he loves spending time with his wife, three children, and their dog, often exploring the beautiful landscapes of the Bay Area. A passionate traveler, he has visited over 70 countries, embracing new cultures along the way. When he’s not seeing patients, you’ll likely find him discovering new restaurants or relaxing with a good cup of coffee or a glass of wine. He also enjoys hiking, playing tennis, and enthusiastically cheering on his favorite soccer team, Real Madrid.

Read More
  • Residency: Obstetrics and Gynecology, Brigham and Women’s Hospital and Massachusetts General Hospital
  • Fellowship: Reproductive Endocrinology and Infertility, University of California San Francisco (UCSF)
  • Pacific Coast Reproductive Society Student Scholarship
  • Massachusetts General Hospital Research Day, Best Ob/Gyn Poster
  • Hispanic Health Professional Student Scholarship
  • Paul and Daisy Soros Scholarship for New Americans
  • Phi Beta Kappa Honor Society
  • Golden Key Honor Society

  • Kochersberger A, Coakley A, Millheiser L, Morris JR, Manneh C, Jackson A, Garrison JL, Hariton E. The association of race, ethnicity, and socioeconomic status on the severity of menopause symptoms: a study of 68,864 women. Menopause. 2024 Jun 1;31(6):476-483.
  • Pavlovic ZJ, Jiang VS, Hariton E. Current applications of artificial intelligence in assisted reproductive technologies through the perspective of a patient’s journey. Curr Opin Obstet Gynecol. 2024 Aug 1;36(4):211-217.  
  • Fine E, Libby VR, Hariton E., Vaught KCC, Anderson KL, Chen SH, Forman EJ, Omurtag K, Trivax BS. Evaluating the utility of a global webinar for mentoring medical students and OBGYN residents in REI. J Educ Health Promot. 2023 Nov 27;12:421. doi: 10.4103/jehp.jehp_1608_22.
  • Jiang VS, Pavlovic ZJ, Hariton E. The Role of Artificial Intelligence and Machine Learning in Assisted Reproductive Technologies. Obstet Gynecol Clin North Am. 2023 Dec;50(4):747-762
  • Jaswa EG, Lindquist KJ, Hariton E., Aliaga KE, Cedars MI, Huddleston HG. Association between social media use for medical information during pregnancy and likelihood of vaccination against COVID-19. AJOG Glob Rep. 2023 Aug 17;3(4):100262.  
  • Hariton E., Alvero R, Hill MJ, Mersereau JE, Perman S, Sable D, Wang F, Adamson GD, Coutifaris C, Craig LB, Hosseinzadeh P, Imudia AN, Johnstone EB, Lathi RB, Lin PC, Marsh EE, Munch M, Richard-Davis G, Roth LW, Schutt AK, Thornton K, Verrilli L, Weinerman RS, Young SL, Devine K. Meeting the demand for fertility services: the present and future of reproductive endocrinology and infertility in the United States. Fertil Steril. 2023 Oct;120(4):755-766.
  • Hariton E., Andrusier MA, Khorshid A. Timing intrauterine inseminations: Do we need an ultrasound, or can artificial intelligence do the trick? Fertil Steril. 2023 Nov;120(5):985-986
  • Hariton E., Morris JR, Ho K, Chen C, Cui E, Cedars MI. The effect of the coronavirus disease 2019 vaccine and infection on menstrual cycle length: an analysis of 12 months of continuous menstrual cycle data from 5,314 participants. Fertil Steril. 2023
  • Hariton E., Pavlovic Z, Fanton M, Jiang VS. Applications of artificial intelligence in ovarian stimulation: a tool for improving efficiency and outcomes. Fertil Steril. 2023 Jul;120(1):8-16.  
  • Hariton E., Andrusier M, Fine E. Recurrent implantation failure: Are we throwing Hail Mary on Third Down? Fertil Steril. 2023 Jul;120(1):60
  • Andrusier MA, Hariton E., Raker CA, Frishman GN, Feinberg EC. Should virtual Reproductive Endocrinology and Infertility fellowship interviews continue beyond COVID-19? Applicant and program directors’ perspectives. Am J Obstet Gynecol. 2023 Mar;228(3):346-349.
  • Bortoletto P, Keefe KW, Unger E, Hariton E., Gargiulo AR. Incidence and risk factors of intrauterine adhesions after myomectomy. F S Rep. 2022 May 28;3(3):269-274.
  • Fanton M, Nutting V, Rothman A, Maeder-York P, Hariton E., Barash O, Weckstein L, Sakkas D, Copperman AB, Loewke K. An interpretable machine learning model for individualized gonadotrophin starting dose selection during ovarian stimulation. Reprod Biomed Online. 2022 Dec;45(6):1152-1159.
  • Fanton M, Nutting V, Solano F, Maeder-York P, Hariton E., Barash O, Weckstein L, Sakkas D, Copperman AB, Loewke K. An interpretable machine learning model for predicting the optimal day of trigger during ovarian stimulation. Fertil Steril. 2022 Jul;118(1):101-108.  
  • Morris JR, Jaswa E, Kaing A, Hariton E., Andrusier M, Aliaga K, Davis M, Cedars MI, Huddleston HG. Early pregnancy anxiety during the COVID-19 pandemic: preliminary findings from the UCSF ASPIRE study. BMC Pregnancy Childbirth. 2022 Mar 31;22(1):272.
  • Huddleston HG, Jaswa EG, Lindquist KJ, Kaing A, Morris JR, Hariton E., Corley J, Hoskin E, Gaw SL, Cedars MI. COVID-19 vaccination patterns and attitudes among American pregnant individuals. Am J Obstet Gynecol MFM. 2021 Oct 11;4(1):100507.
  • Sacha CR, Mortimer R, Hariton E., James K, Hosseini A, Gray M, Xuan C, Hammer K, Lange A, Mahalingaiah S, Wang J, Petrozza JC. Assessing efficacy of IV acetaminophen for perioperative pain control for oocyte retrieval: a randomized, double blind, placebo-controlled trial. Fertil Steril. 2022 Jan;117(1):133-141.
  • Romanski PA, Hariton E. Current Obstetrics and Gynecology Reports. In press.
  • Hariton E., Morris JR, Portugal A, Anderson-Bialis J, Anderson-Bialis D, Cedars MI. Prevalence and characteristics of patients declined from pursuing in vitro fertilization with autologous oocytes. J Assist Reprod Genet. 2021 Oct;38(10):2679-2685.
  • Hariton E. Medication management in the 21st century: There should be an app for that! Fertil Steril. 2021 Sep;116(3):674-675.
  • Hariton E., Raker CA, Frishman GN, Feinberg EC. Perceptions and lessons from web-based interviews for the reproductive endocrinology and infertility fellowship application cycle. Fertil Steril. 2021 Sep;116(3):872-881.
  • Wald K, Hariton E., Morris JR, Chi EA, Jaswa EG, Cedars MI, McCulloch CE, Rosen M. Changing stimulation protocol on repeat conventional ovarian stimulation cycles does not lead to improved laboratory outcomes. Fertil Steril. 2021 Sep;116(3):757-765. doi: 10.1016/j.fertnstert.2021.04.030. Epub 2021 May 24
  • Hariton E., Chi EA, Chi G, Morris JR, Braatz J, Rajpurkar P, Rosen M. A Machine Learning Algorithm can Optimize the Day of Trigger to Improve In Vitro Fertilization Outcomes. Fertil Steril. 2021 Jul 10:S0015-0282(21)00512-4.
  • Hariton E., Shirazi TN, Douglas NC, Hershlag A, Briggs SF. Anti-Müllerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals. Am J Obstet Gynecol. 2021 Jun 12:S0002-9378(21)00685-2
  • Evans BM, Alexander C, Barnard E, Ezzati MM, Hill MJ, Hoyos LR, Hariton E., Mikhael S, Penzias A. Consider This: COVID-19. Fertility and Sterility Dialog. 2021
  • Insogna I, Lanes A, Hariton E., Blake-Lamb T, Boyle J, Schilling S, Hornstein MD. Self-reported barriers to accessing infertility care: patient perspectives from urban gynecology clinics. Journal of Assisted Reproduction and Genetics. J Assist Reprod Genet. 2020 Dec;37(12):3007-3014.
  • Bormann CL, Kanakasabapathy MK, Thirumalaraju P, Gupta R, Pooniwala R, Kandula H, Hariton E., Souter I, Dimitriadis I, Shafiee H. Performance of a deep learning based neural network in the selection of human blastocysts for implantation. Elife. 2020 Sep 15;9:e55301. doi: 10.7554/eLife.55301
  • Hariton E. Fertility and Sterility Dialog [Internet]. Fellowship interviews in the COVID-19 era: an opportunity for lasting change. 2020 July
  • Hariton E., Tracy EE. Telemedicine Companies Providing Prescription-Only Medications: Pros, Cons, and Proposed Guidelines. Obstet Gynecol, 2019 Nov;134(5):941-945.
  • Hariton E., Dolisca S, Bortoletto P. The Residency Interview Season: Time for Commonsense Reform. Obstet Gynecol. 2019 Apr;133(4):824.
  • Harris AL, Vanegas JC, Hariton E., Bortoletto P, Palmor M, Humphries LA, Tanrikut C, Chavarro JE, Styer AK. Semen parameters on the day of oocyte retrieval predict low fertilization during conventional insemination IVF cycles. J Assist Reprod Genet. 2019 Feb;36(2):291-298
  • Hariton E., Freret TS, Nitecki R, Hinchcliff EM, Stagg AR. Program Director Perceptions of Subspecialty Tracking in Obstetrics and Gynecology Residency. Journal of Graduate Medical Education: December 2018, Vol. 10, No. 6, pp. 665-670.
  • Hariton E., Locascio J. Randomized Controlled Trials: the gold standard for effectiveness research. British Journal of Obstetrics and Gynaecology. 2018 Dec;125(13):1716.
  • Hariton, E, Bortoletto, P, Barnes, KL, Kaimal, AJ, Stagg, AR. Resident and Program Director’s Perceptions of Milestone-Based Feedback in Obstetrics and Gynecology. Journal of Medical Education and Curricular Development. 2018 May 20;5:2382120518774794.
  • Hariton, E, Matthews, B, Burns, A, Akileswaran, C, Berkowitz, LR. Pregnancy and Parental Leave among Obstetrics and Gynecology Residents: Results of a Nationwide Survey of Program Directors. American Journal of Obstetrics & Gynecology. 2018 Aug;219(2):199.e1-199.e8.
  • Bortoletto P, Hariton E., Gargiulo AR. Evolution of Myomectomy: From Laparotomy to Minimally Invasive Surgery. British Journal of Obstetrics and Gynaecology. 2018, Mar; 125(5): 586.
  • Hariton E., Bortoletto P, Goldman RH, Farland LV, Ginsburg ES, Gargiulo AR. A Survey of Public Opinion in the United States Regarding Uterine Transplantation. Journal of Minimally Invasive Surgery. 2018 Mar 7. pii: S1553-4650(18)30153-5.
  • Bortoletto P, Hariton E., Goldman RH, Farland LV, Gargiulo AR. Uterine Transplantation: A Survey of Perceptions and Attitudes of American Reproductive Endocrinologists and Gynecologic Surgeons. Journal of Minimally Invasive Surgery. 2018 Mar 1. pii: S1553-4650(18)30143-2.
  • Hariton E., Pieh-Holder K, Bortoletto P, Lindsey J, Walsh B, Anchan R, DeVente J. Abdominopelvic Dissemination of Benign Uterine Tissue Following Surgical Power Morcellation. Clin Obstet Gynecol Reprod Med. 2017, Dec; 3(6): 1-4.
  • Hariton E., Kim K, Mumford SL, Palmor M, Bortoletto P, Cardozo ER, Karmon AE, Sabatini ME, Styer AK. Total number of oocytes and zygotes are predictive of live birth pregnancy in fresh donor oocyte in vitro fertilization cycles. Fertil Steril. 2017, Aug; 108(2): 262-268.
  • Hariton E., Bortoletto P, Walsh BW, Devente JE, Anchan RM. Disseminated Endometriosis and Leiomyomatosis Following Power Morcellation. J Reproductive Endocrinol Infert. 2017, Aug; 2(2): 24
  • Bortoletto P, Hariton E., Salas S, Cohen SL. Update on Fibroid Morcellation. Curr Obstet Gynecol Rep. 2017, 6(1): 62-66.
  • Hariton E., Bortoletto P, Ayogu N. Utilizing Video-Conference Interviews in the Residency Application Process. Academic Medicine. 2017, Jun; 92(6): 728-729.
  • Hariton E., Bortoletto P, Cardozo E, Hochberg E, Sabatini M. The Role of Oncofertility Clinics in Facilitating Access to Reproductive Specialists. Journal of Patient Experience. 2016, Dec; 3(4): 131-136.
  • Cohen SL, Hariton E., Afshar Y, Siedhoff MT. Updates in uterine fibroid tissue extraction. Curr Opin Obstet Gynecol. 2016, Aug; 28(4): 277-82.
  • Hariton E., Bortoletto P, Ayogu N. Residency Interviews in the 21st Century. J Grad Med Educ. 2016, Jul; 8(3): 322-4.
  • Choussein S, Hariton E., Bortoletto P, Gargiulo AR. Current trends and controversies in reproductive surgery. Minerva Ginecol. Mar; 66(6): 700-12.
  • Rauh-Hain J, Hariton E., Clemmer J, Clark R, Hall T, Boruta D, Schorge J, Del Carmen M. Incidence and Impact of Venous Thromboembolism on Mortality of Elderly Women with Endometrial Cancer. Obstetrics and Gynecology. Obstet Gynecol. 2015, Jun; 125(6): 1362-70.
  • Hariton E., Lester M, and Richards JB. An Atypical Cause of Chest Pain: An Octopus Trap. MedEdPORTAL Publications. Epub Mar 14, 2014.
  • Tucker CM, Lopez MT, Campbell K, Marsiske M, Daly K, Nghiem K, Rahim-Williams B, Jones J, Hariton E., and Patel A. The effects of a culturally sensitive, empowerment-focused, community-based health promotion program on health outcomes of adults with type 2 diabetes. J Health Care Poor Underserved. 2014, Feb; 25(1): 292-307.
  • Cohen J, Hariton E., Kothari D, Pihan GA, Robson SC. Hepatosplenic alpha/beta T-cell lymphoma masquerading as cirrhosis. J Gastrointest Oncol. 2013, Jun; 4(2): 131-6.
  • Cohen JM, Fagin AP, Hariton E., Niska JR, Pierce MW, Kuriyama A, Whelan JS, Jackson JL, Dimitrakoff JD. Therapeutic Intervention for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): A Systematic Review and Meta-Analysis. PLoS One. PLoS One. 2012, Aug; 7(8).

Dr. Hariton is caring, educated, pragmatic, and a great listener. He really took the time to understand our needs and was always there to relieve our nervousness with optimism and data. He ensured we had all the information we wanted/needed and maximized our chances with a tailor-made treatment plan

I had a great experience with Dr. Hariton. He set me at ease and was very kind, professional and knowledgeable. I had a great result. Definitely would recommend working with Dr. Hariton.

Dr. Hariton and his team were very professional and caring. His level of knowledge and attention to details made a difference to deliver realistic results. My wife and I are extremely satisfied with the experience and would highly recommend him to walk and lead you through the IVF process.

My husband and I are so grateful we had the opportunity to work with Dr. Hariton. We felt at ease with him from our very first appointment all the way through our successful transfer. He was kind, informative, calm, always open to questions, and so present with us through the entire process.

Dr. Hariton’s approach was both professional and deeply compassionate, ensuring we felt confident in our decisions by walking us through each option available. This personalized approach made us feel genuinely understood and supported.

Make an appointment today

Request an Appointment